QuidelOrtho Earnings: What To Look For From QDEL
Craig-Hallum Maintains QuidelOrtho(QDEL.US) With Buy Rating
QuidelOrtho Insider Ups Holding During Year
Earnings Preview: QuidelOrtho to Report Financial Results Post-market on May 07
Analysts Conflicted on These Healthcare Names: QuidelOrtho (QDEL) and Enliven Therapeutics (ELVN)
William Blair Maintains QuidelOrtho(QDEL.US) With Hold Rating
Press Release: QuidelOrtho to Report First Quarter 2025 Financial Results
QuidelOrtho Is Maintained at Underweight by JP Morgan
QuidelOrtho Analyst Ratings
J.P. Morgan Maintains QuidelOrtho(QDEL.US) With Sell Rating, Cuts Target Price to $25
J.P. Morgan Keeps Their Sell Rating on QuidelOrtho (QDEL)
RBC Capital Maintains QuidelOrtho(QDEL.US) With Buy Rating, Maintains Target Price $60
QuidelOrtho Corporation (NASDAQ:QDEL) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
QuidelOrtho (QDEL) Gets a Buy From RBC Capital
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
QuidelOrtho (NASDAQ:QDEL Shareholders Incur Further Losses as Stock Declines 7.1% This Week, Taking Three-year Losses to 66%
QuidelOrtho Introduces Results Manager System
Is QuidelOrtho Corporation (QDEL) the Best Medical Technology Stock to Buy According to Analysts?